Alcon Inc. (NYSE:ALC) has announced that the U.S. Food and Drug Administration (FDA) has approved TRYPTYR (acoltremon ...

Eye-care drugmaker Alcon said on Wednesday that the U.S. Food and Drug Administration has approved its treatment for dry eye ...

Jasmine Paolini moved into the French Open third round on Wednesday as Iga Swiatek continued her bid for a fourth straight ...

The shelter faces a downturn in funding that aligns with a national trend, spurred by economic uncertainty, inflation and ...

For the first time this offseason, Aaron Rodgers has offered a big hint on whether he plans to play in the NFL this year. The ...

A specific vitamin supplement appears to slow glaucoma-related optic nerve damage, even without lowering eye pressure. A ...

Bausch + Lomb launched a preservative-free form of Lumify redness-reducing eye drops in the U.S., according to a press ...

Dollar slides for first week in five as U.S. deficit fears mount. Technicals point lower with traders watching 98.901 for ...

The FDA cleared an investigational new drug application for a phase 2 trial of GRF312 ophthalmic solution, an immunoglobulin ...